What is an enterocutaneous fistula?
Enterocutaneous fistula is an abnormal connection between large or small intestines and skin, and allows the intestinal tract content to flow from the body suddenly, opening or injuries. The condition occurs due to surgery, traumatic injuries or diseases. Enterocutaneous fistula is difficult to treat and has high mortality.
The condition may occur for various reasons. After surgery, an enterocutaneous fistula may occur. Patients who receive cancer therapy in the form of abdominal radiation are at risk of developing an enterocutanate fistula. Individuals who have the conditions of inflammatory intestine, and people who got wounds into the abdomen through traumatic damage, such as wound stings or gunshot wounds are also at risk. Some patients are dehydrated or malnourished. Others develop infections at the site of the injury. The main organs in the body have arisen and the body goes into shock from low blood pressure. Sepse can lead to death.
The physician may diagnose the enterocutaneous fistula by examining the patient's physical symptoms. He could also perform other tests to find out exactly where the fistula occurred. Several of these tests include studies of gastrointestinal contrast, scanning computed tomography (CT) and ultrasound.
Doctors solve the condition by draining the abscess wound and the provision of nutrients and liquids for the patient to combat nutritional imbalances and malnutrition. They can also prescribe antibiotics drugs to control infections. Fistulas that do not respond to therapy within four to six weeks require more drastic treatment methods.
surgeons can work on fistulas to close it if necessary, especially if the wound seems to grow more infected or develops gangrene. Perhaps they will have to remove part of the intestinal tract and fistula to get infections under control if the wound does not heal. Doctors can also close enterocutaneous fistula using fibrin adhesive, which is Biological LepiDlo.
The recovery prognosis varies depending on the patient. The mortality rate is usually 5-20 percent. Most patients who succumb to complications from enterocutan fistulas usually lose their lives due to loss of fluids or electrolytes, sepsis infections and malnutrition. People who were generally healthy from the development of fistula have an excellent chance of complete recovery.